SCHEMBL6002215

SCHEMBL6002215

CN1CCN(C2CCOc3ccccc32)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 3/20 0.45
HTR6 P50406 1/20 0.43
DPP4 P27487 1/20 0.41
CHRNA7 P36544 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR7 P34969 1/20 0.39
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRM3 P20309 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
HRH1 P35367 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29675238 1.00 OPRL1 (0.45) OPRL1HTR6DPP4CHRNA7MEN1
SCHEMBL7814997 0.94 CHRNA7 (0.43) OPRL1HTR6DPP4CHRNA7CHRM2
SCHEMBL31011763 0.81 HTR6 (0.62) OPRL1HTR6DPP4CHRNA7ALDH1A1
Hydrochloric Acid SCHEMBL6421115 0.80 HTR6 (0.60) OPRL1HTR6DPP4CHRNA7ALDH1A1
SCHEMBL6410570 0.80 ALDH1A1 (0.42) HTR6MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL7832801 0.79 OPRL1 (0.40) OPRL1HTR6DPP4CHRNA7HTR2B
SCHEMBL7824788 0.77 HTR6 (0.57) OPRL1HTR6DPP4CHRNA7KMT2A
SCHEMBL7837293 0.77 HTR6 (0.57) OPRL1HTR6DPP4CHRNA7KMT2A
SCHEMBL6422733 0.76 GPR119 (0.46) OPRL1DPP4ALDH1A1CHRM2CHRM1
SCHEMBL7827208 0.74 HCRTR1 (0.54) OPRL1ALDH1A1KMT2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166984-A1 Amino substituted benzo(hetero)cyclic derivatives BASF AKTIENGESELLSCHAFT (DE) 2006-07-27 US disclosed
EP-1603395-A2 AMINO SUBSTITUTED BENZO(HETERO)CYCLIC DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2005-12-14 EP disclosed
WO-2004080170-A2 AMINO SUBSTITUTED BENZO(HETERO)CYCLIC DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166984-A1 Amino substituted benzo(hetero)cyclic derivatives CBR3, L3MBTL3, BRS3 OPRL1 806/4885HTR6 2006/4885DPP4 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.